Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 CEO 906 - YUMANITY THERAPEUTICS, INC. | pti-ex321_6.htm |
| EX-31.2 - EX-31.2 CFO - YUMANITY THERAPEUTICS, INC. | pti-ex312_9.htm |
| EX-31.1 - EX-31.1 CEO - YUMANITY THERAPEUTICS, INC. | pti-ex311_7.htm |
| EX-10.21 - EX-10.21 MUNOZ EMPLOYMENT AGREEMENT - YUMANITY THERAPEUTICS, INC. | pti-ex1021_125.htm |
| EX-10.13 - EX-10.13 NON-EMPLOYEE DIRECTOR COMPENSATION POLICY - YUMANITY THERAPEUTICS, INC. | pti-ex1013_126.htm |
| 10-K - 10-K - YUMANITY THERAPEUTICS, INC. | pti-10k_20171231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S‑8 (No. 333-218544 and No. 333-210521) and Form S-3 (No. 333-218545) of Proteostasis Therapeutics, Inc. of our report dated March 14, 2018 relating to the financial statements, which appears in this Form 10K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 14, 2018